The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.

IF 1.8 4区医学 Q3 RHEUMATOLOGY Modern Rheumatology Pub Date : 2024-10-23 DOI:10.1093/mr/roae096

Masatoshi Kanda, Ken Nagahata, Masafumi Moriyama, Ken-Ichi Takano, Ryuta Kamekura, Hajime Yoshifuji, Hiroto Tsuboi, Motohisa Yamamoto, Hisanori Umehara, Masataka Umeda, Mizuki Sakamoto, Takashi Maehara, Yoshino Inoue, Satoshi Kubo, Tetsuo Himi, Tomoki Origuchi, Yasufumi Masaki, Tsuneyo Mimori, Hiroaki Dobashi, Yoshiya Tanaka, Seiji Nakamura, Hiroki Takahashi

{"title":"The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.","authors":"Masatoshi Kanda, Ken Nagahata, Masafumi Moriyama, Ken-Ichi Takano, Ryuta Kamekura, Hajime Yoshifuji, Hiroto Tsuboi, Motohisa Yamamoto, Hisanori Umehara, Masataka Umeda, Mizuki Sakamoto, Takashi Maehara, Yoshino Inoue, Satoshi Kubo, Tetsuo Himi, Tomoki Origuchi, Yasufumi Masaki, Tsuneyo Mimori, Hiroaki Dobashi, Yoshiya Tanaka, Seiji Nakamura, Hiroki Takahashi","doi":"10.1093/mr/roae096","DOIUrl":null,"url":null,"abstract":"Objectives: For the diagnosis of IgG4-related dacryoadenitis and sialadenitis, either revised comprehensive diagnostic criteria or organ-specific diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis in 2008 were applied; however, the collected knowledge for IgG4-related dacryoadenitis and sialadenitis required us to revise the criteria for IgG4-related dacryoadenitis and sialadenitis.Methods: The board member of Japanese Study Group for IgG4-related Dacryoadenitis and Sialadenitis revised the diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis. We collected the clinical questions to be revised and performed a review of the literature. When the data were insufficient, additional data collection was performed. After the revision, public comments were collected.Results: The three major points were revised. 1. Asymmetric or under two pairs of dacryoadenitis and sialoadenitis were included as IgG4-related dacryoadenitis and sialadenitis. 2. The thresholds of IgG4-positive cell infiltration were adjusted to an IgG4+/IgG+ ratio >0.4 and IgG4+ cells >10 per high power field. 3. The labial salivary gland biopsy was allowed to diagnose IgG4-related dacryoadenitis and sialadenitis.Conclusions: The revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis solved several issues with the previous criteria. It will improve the early diagnosis of IgG4-related dacryoadenitis and sialadenitis, especially in situations without enough resources for a biopsy.","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mr/roae096","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: For the diagnosis of IgG4-related dacryoadenitis and sialadenitis, either revised comprehensive diagnostic criteria or organ-specific diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis in 2008 were applied; however, the collected knowledge for IgG4-related dacryoadenitis and sialadenitis required us to revise the criteria for IgG4-related dacryoadenitis and sialadenitis.

Methods: The board member of Japanese Study Group for IgG4-related Dacryoadenitis and Sialadenitis revised the diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis. We collected the clinical questions to be revised and performed a review of the literature. When the data were insufficient, additional data collection was performed. After the revision, public comments were collected.

Results: The three major points were revised. 1. Asymmetric or under two pairs of dacryoadenitis and sialoadenitis were included as IgG4-related dacryoadenitis and sialadenitis. 2. The thresholds of IgG4-positive cell infiltration were adjusted to an IgG4+/IgG+ ratio >0.4 and IgG4+ cells >10 per high power field. 3. The labial salivary gland biopsy was allowed to diagnose IgG4-related dacryoadenitis and sialadenitis.

Conclusions: The revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis solved several issues with the previous criteria. It will improve the early diagnosis of IgG4-related dacryoadenitis and sialadenitis, especially in situations without enough resources for a biopsy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2023 年修订的 IgG4 相关泪腺炎和唾液腺炎诊断标准。

目的：为了诊断 IgG4 相关性泪腺炎和浆液性泪腺炎，我们采用了 2008 年修订的 IgG4 相关性泪腺炎和浆液性泪腺炎综合诊断标准或器官特异性诊断标准；但是，根据收集到的有关 IgG4 相关性泪腺炎和浆液性泪腺炎的知识，我们需要修订 IgG4 相关性泪腺炎和浆液性泪腺炎的诊断标准：日本 IgG4 相关性泪腺炎和唾液腺炎研究小组的理事会成员修订了 IgG4 相关性泪腺炎和唾液腺炎的诊断标准。我们收集了需要修订的临床问题，并对文献进行了回顾。当数据不足时，我们进行了额外的数据收集。修订后，我们还收集了公众意见：结果：修订了三个要点。1.将不对称或两对以下的泪腺炎和泪囊炎列为 IgG4 相关泪腺炎和泪囊炎。2.2. IgG4 阳性细胞浸润的阈值调整为 IgG4+/IgG+ 比值 >0.4 和 IgG4+ 细胞 >10 个/高倍视野。3.3. 唇唾液腺活检可用于诊断 IgG4 相关性泪腺炎和唾液腺炎：修订后的 IgG4 相关性泪腺炎和唾液腺炎诊断标准解决了以前标准的几个问题。它将改善 IgG4 相关性泪腺炎和泪腺炎的早期诊断，尤其是在没有足够资源进行活组织检查的情况下。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Modern Rheumatology RHEUMATOLOGY-

CiteScore

4.90

自引率

9.10%

发文量

146

审稿时长

1.5 months

期刊介绍： Modern Rheumatology publishes original papers in English on research pertinent to rheumatology and associated areas such as pathology, physiology, clinical immunology, microbiology, biochemistry, experimental animal models, pharmacology, and orthopedic surgery. Occasional reviews of topics which may be of wide interest to the readership will be accepted. In addition, concise papers of special scientific importance that represent definitive and original studies will be considered. Modern Rheumatology is currently indexed in Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, PubMed/Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, CSA, Academic OneFile, Current Abstracts, Elsevier Biobase, Gale, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions